Brief: Heidelberg Pharma H1 Net Loss Narrows To EUR 4.3 Mln

Heidelberg Pharma AG

11/07/2019 06:13

July 11 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * H1 SALES REVENUE UP BY 88% YOY
    * H1 SALES REVENUE AND INCOME TOTALING EUR 4.1 MILLION
    * NET LOSS FOR FIRST HALF OF YEAR WAS REDUCED TO EUR 4.3
MILLION
FROM EUR 4.7 MILLION FOR SAME PERIOD IN 2018
    * CONFIRMS ITS GUIDANCE FOR CURRENT FISCAL YEAR PROVIDED AT
END OF
MARCH 2019.
    * CASH AND CASH EQUIVALENTS OF EUR 13.1 MILLION ON 31 MAY
2019 (30
NOVEMBER 2018: EUR 19.4 MILLION)
    * H1 OPERATING LOSS EUR 4.3 MILLION VERSUS EUR 4.7 MILLION
YEAR
AGO

Source text for Eikon:  ID:nEQ22y8QMa 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((Gdynia.Newsroom@thomsonreuters.com; +48587020920;))